[Expression and Clinical Significance of Progesterone and Adiponectin Receptor Family Member 3 in Lung Cancer]
- PMID: 28442015
- PMCID: PMC5999676
- DOI: 10.3779/j.issn.1009-3419.2017.04.06
[Expression and Clinical Significance of Progesterone and Adiponectin Receptor Family Member 3 in Lung Cancer]
Abstract
Background: Progesterone and adiponectin receptor family member 3 (PAQR3) is a recently discovered tumor suppressor gene, which affects the development of a tumor by inhibiting cell proliferation, cell malignant transformation, angiogenesis, and tumor metastasis. This study investigates the expression of PAQR3 in lung cancer and its clinical significance.
Methods: A total of 106 patients with lung cancer received surgical treatment in hospital, and adjacent normal tissues of these patients were utilized as control group. The diagnosis of all patients was confirmed through clinical pathology. The expression of PAQR3 protein was detected by immunohistochemistry in lung cancer and adjacent normal tissues. The clinical significance of its expression was also investigated.
Results: The positive expression rate of PAQR3 protein in lung cancer was lower than that in adjacent normal tissues (P<0.01). The positive expression rate of PAQR3 protein was unrelated to age, tumor size, and gender, but it exhibited a significant relationship with the pathological type and differentiation, TNM staging, and lymph node metastasis (P<0.05). Kaplan-Meier survival analysis showed that the five-year survival rate of patients with PAQR3 protein positive expression was higher than that in patients with negative expression (P=0.026).
Conclusions: The expression of PAQR3 protein significantly decreased in lung cancer, indicating that PAQR3 protein plays an important role in the pathogenesis of PAQR3 in lung cancer.
背景与目的 孕酮及脂联素受体家族成员3(progesterone and adiponectin receptor family member 3, PAQR3)是最新研究发现的抑癌基因,通过抑制细胞增殖、细胞恶性转化、抑制血管生成及肿瘤转移来影响肿瘤的发展。本研究旨在探讨PAQR3在肺癌组织中的表达及其临床意义。方法 选取天津医科大学总医院病理科2008年1月-2010年12月经病理明确诊断的106例肺癌组织标本作为实验组,同时取其癌旁正常组织作为对照。所有患者的诊断均经术后病理诊断证实,采用免疫组织化学方法检测PAQR3蛋白在肺癌组织和癌旁正常组织中的表达,并探讨其表达的临床意义。结果 PAQR3蛋白在肺癌组织中阳性表达率显著低于癌旁正常组织(P<0.01);PAQR3蛋白的阳性表达率与患者的性别、年龄、肿瘤大小无关,与患者的病理分型、分化程度、TNM分期和有无淋巴结转移具有相关性(P<0.05);Kaplan-Meier生存分析结果显示PAQR3蛋白阳性表达的患者5年生存率高于阴性表达的患者(P<0.05)。结论 PAQR3蛋白的表达量在肺癌组织中明显降低,提示PAQR3可能在肺癌的发病机制中发挥重要的作用。.
Figures


Similar articles
-
Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.Oncol Rep. 2014 Dec;32(6):2687-95. doi: 10.3892/or.2014.3532. Epub 2014 Oct 6. Oncol Rep. 2014. PMID: 25310770
-
PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling.Biomed Pharmacother. 2017 Oct;94:813-819. doi: 10.1016/j.biopha.2017.07.154. Epub 2017 Aug 10. Biomed Pharmacother. 2017. PMID: 28802234
-
PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expression.Oncotarget. 2015 May 20;6(14):12357-68. doi: 10.18632/oncotarget.3657. Oncotarget. 2015. PMID: 25900239 Free PMC article.
-
PAQR3: a novel tumor suppressor gene.Am J Cancer Res. 2015 Aug 15;5(9):2562-8. eCollection 2015. Am J Cancer Res. 2015. PMID: 26609468 Free PMC article. Review.
-
The Emerging Roles and Mechanisms of PAQR3 in Human Cancer: Pathophysiology and Therapeutic Implications.Int J Gen Med. 2023 Sep 22;16:4321-4328. doi: 10.2147/IJGM.S422523. eCollection 2023. Int J Gen Med. 2023. PMID: 37767187 Free PMC article. Review.
Cited by
-
Downregulation of PAQR3 expression predicts poor prognosis of patients with pan-cancer: a meta-analysis.Front Oncol. 2025 May 5;15:1574150. doi: 10.3389/fonc.2025.1574150. eCollection 2025. Front Oncol. 2025. PMID: 40391162 Free PMC article. Review.
-
PAQR3 Inhibits Non-small Cell Lung Cancer Growth by Regulating the NF-κB/p53/Bax Axis.Front Cell Dev Biol. 2020 Oct 6;8:581919. doi: 10.3389/fcell.2020.581919. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33123538 Free PMC article.
References
-
- Ma Z, Wang Y, Piao T, et al. The tumor suppresser role of PAQR3 in osteosarcoma. https://link.springer.com/article/10.1007/s13277-014-2964-z Tumour Biol. 2016;36(5):3319–3324. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical